The Whole Health Study: Collaborative Care for OUD and Mental Health Conditions
NCT04245423 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 567
Last updated 2026-04-02
Summary
Collaborative care for mental health is increasingly common, but most primary care practices have not embraced similar models for opioid use disorder (OUD). This study will refine and test a collaborative care model for patients with opioid use disorder (OUD) and depression, anxiety or post-traumatic stress disorder (PTSD) in primary care. We also will examine clinician and practice characteristics associated with successful implementation and the cost effectiveness of different care models.
Conditions
- Opioid-use Disorder
- Mental Health Conditions
Interventions
- BEHAVIORAL
-
Collaborative Care for Opioid Use Disorders and Mental Health Conditions
CC is delivered using the investigators' Foundations for Integrated Care model. The first line pharmacotherapy is buprenorphine-naloxone. The second line pharmacotherapy included is extended-release injectable naltrexone. Pharmacotherapy is accompanied by brief problem-solving therapy, cognitive-behavioral therapy, and/or motivational interviewing. The primary care physician, in consultation with the addictions psychiatrist and care manager, also will provide psychotropic medications for psychiatric disorders. In-person and telephone visits consist of the care manager carrying out intervention activities over 6 months. Visits are at baseline (90-minute intake appointment), home or office induction when in moderate opiate withdrawal if buprenorphine is prescribed, twice a week for two weeks with telephone calls in between visits, then weekly, and when stable once a month. There will be a final visit at 6 months. The intervention includes routine collection of urine drug screens.
- BEHAVIORAL
-
Augmented Usual Care
If not already waivered, PCPs will be trained and waivered to treat OUD with medications. All practices will have mental health clinicians to treat mild psychiatric disorders. Other than that, the research team will provide no support to the PCP or practice staff. However, an addiction psychiatrist is available for consultation for OUD.
- BEHAVIORAL
-
Collaborative Care for Opioid Use Disorders and Mental Health Conditions Plus Certified Recovery Specialists
This intervention includes the Collaborative Care Intervention plus Certified Recovery Specialist to assist with treatment engagement and retention.
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
collaborator NIH - lead OTHER
Principal Investigators
-
David Mandell, ScD · University of Pennsylvania
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-12-15
- Primary Completion
- 2025-03-28
- Completion
- 2026-03-28
Countries
- United States
Study Locations
More Related Trials
-
Therapy and Peer Support for Patients Taking Medication for Opioid Use Disorder
NCT04257214 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Telehealth Treatment for Opioid Use Disorders
NCT05832879 ·Status: COMPLETED ·Phase: NA
-
Treatment of Pregnant Women With OUD
NCT04240392 ·Status: COMPLETED ·Phase: NA
-
Subthreshold Opioid Use Disorder Prevention (STOP) Trial
NCT04218201 ·Status: COMPLETED ·Phase: NA
-
Intervening on Opioid Use and Loneliness
NCT06458335 ·Status: RECRUITING ·Phase: NA
-
Collaborative Opioid Taper After Trauma: Preventing Opioid Misuse and Opioid Use Disorder
NCT04275258 ·Status: UNKNOWN ·Phase: NA
-
Examining an Adaptive Approach to Providing Psychosocial Support to Buprenorphine Patients
NCT04650386 ·Status: COMPLETED ·Phase: NA
-
Digital Intervention to Treat Anxiety and Depression Among Persons Receiving Treatment for Opioid Use Disorder
NCT05047627 ·Status: COMPLETED ·Phase: NA
-
Integrated Treatment for Opioid Use Disorder and PTSD
NCT06641115 ·Status: RECRUITING ·Phase: NA
-
Collaborative Care for Polysubstance Use in Primary Care Settings (Co-Care)
NCT06116266 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Psilocybin for Opioid Use Disorder (OUD)
NCT06796062 ·Status: RECRUITING ·Phase: PHASE2
-
Behavioral Activation for Opioid Use Disorder
NCT05262725 ·Status: COMPLETED ·Phase: NA
-
Pain Self-Management and Treatment Engagement for Patients Taking Opioids
NCT06855732 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of Treatment for Opioid Dependence and Anxiety Disorders
NCT02252068 ·Status: COMPLETED ·Phase: NA
-
SafetyNet Program for Opioid Use Disorder (OUD)
NCT04253782 ·Status: COMPLETED ·Phase: NA
-
Therapy for People With Opioid Use Disorder
NCT06008769 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
SMART Trial: Intrapersonal and Interpersonal Stigma Reduction
NCT04693416 ·Status: COMPLETED ·Phase: PHASE2
-
Patient-Centered Care for Opioid Use Disorders in Federally Qualified Healthcare Centers and Specialty Care Settings
NCT03367234 ·Status: WITHDRAWN ·Phase: NA
-
Biopsychosocial Markers of Addiction in Opioid Users: an Integrated Approach
NCT06021548 ·Status: ACTIVE_NOT_RECRUITING
-
Suicide Prediction and Prevention for People at Risk for Opioid Use Disorder: Supplement to COMPUTE 2.0
NCT04939727 ·Status: COMPLETED ·Phase: NA
-
Pilot Testing a Novel Remotely Delivered Intensive Outpatient Program for Individuals With OUD
NCT05817825 ·Status: RECRUITING ·Phase: NA
-
Resilience Among Individuals With Opioid Use Disorder
NCT06954402 ·Status: RECRUITING ·Phase: NA
-
Nudges and Incentives to Enhance the Opioid Treatment Workforce
NCT03834025 ·Status: COMPLETED ·Phase: NA
-
Fathering In Recovery
NCT04611542 ·Status: COMPLETED ·Phase: NA
-
Treatment for Opiate Addiction: Prognostic fActors of Responsiveness to Maintenance Treatment
NCT03729388 ·Status: COMPLETED